Abstract
Human interleukin 1 beta (IL-1 beta) exerts its diverse biological effects by binding to specific receptors on target cells. Two types of IL-1 receptor (IL-1R) have been identified: the type I IL-1R (p80) and the type II IL-1R (p68). Using site-specific mutagenesis, we have identified the binding site on IL-1 beta for the murine type I IL-1R. Analogs of the IL-1 beta protein containing defined amino acid substitutions were produced and tested for competitive binding to the two IL-1Rs. Substitutions of the amino acids at seven positions resulted in analogs that had greater than or equal to 100-fold reductions in competitive binding to the type I IL-1R, while maintaining substantial binding to the type II IL-1R. These seven amino acids (Arg-4, Leu-6, Phe-46, Ile-56, Lys-93, Lys-103, and Glu-105) are clustered in the IL-1 beta molecule, forming a discontinuous binding site. The side chains of all seven residues are exposed on the surface of IL-1 beta. The cumulative binding energies contributed by each of the residues predict a binding affinity that is consistent with the observed Kd of the wild-type protein for the type I IL-1R.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bird T. A., Saklatvala J. Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells. Nature. 1986 Nov 20;324(6094):263–266. doi: 10.1038/324263a0. [DOI] [PubMed] [Google Scholar]
- Bomsztyk K., Sims J. E., Stanton T. H., Slack J., McMahan C. J., Valentine M. A., Dower S. K. Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8034–8038. doi: 10.1073/pnas.86.20.8034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brünger A. T., Kuriyan J., Karplus M. Crystallographic R factor refinement by molecular dynamics. Science. 1987 Jan 23;235(4787):458–460. doi: 10.1126/science.235.4787.458. [DOI] [PubMed] [Google Scholar]
- Carter D. B., Curry K. A., Tomich C. S., Yem A. W., Deibel M. R., Tracey D. E., Paslay J. W., Carter J. B., Theriault N. Y., Harris P. K. Crystallization of purified recombinant human interleukin-1 beta. Proteins. 1988;3(2):121–129. doi: 10.1002/prot.340030207. [DOI] [PubMed] [Google Scholar]
- Chizzonite R., Truitt T., Kilian P. L., Stern A. S., Nunes P., Parker K. P., Kaffka K. L., Chua A. O., Lugg D. K., Gubler U. Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8029–8033. doi: 10.1073/pnas.86.20.8029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chollet A., Bonnefoy J. Y., Odermatt N. Preparation, application and biological characterization of interleukin-1 beta mutant protein biotinylated at a single site. J Immunol Methods. 1990 Mar 9;127(2):179–185. doi: 10.1016/0022-1759(90)90067-6. [DOI] [PubMed] [Google Scholar]
- Clore G. M., Wingfield P. T., Gronenborn A. M. High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. Biochemistry. 1991 Mar 5;30(9):2315–2323. doi: 10.1021/bi00223a005. [DOI] [PubMed] [Google Scholar]
- Dinarello C. A., Bendtzen K., Wolff S. M. Studies on the active site of human leukocytic pyrogen. Inflammation. 1982 Mar;6(1):63–78. doi: 10.1007/BF00910720. [DOI] [PubMed] [Google Scholar]
- Dinarello C. A., Savage N. Interleukin-1 and its receptor. Crit Rev Immunol. 1989;9(1):1–20. [PubMed] [Google Scholar]
- Dower S. K., Kronheim S. R., Hopp T. P., Cantrell M., Deeley M., Gillis S., Henney C. S., Urdal D. L. The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature. 1986 Nov 20;324(6094):266–268. doi: 10.1038/324266a0. [DOI] [PubMed] [Google Scholar]
- Eisenberg S. P., Brewer M. T., Verderber E., Heimdal P., Brandhuber B. J., Thompson R. C. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5232–5236. doi: 10.1073/pnas.88.12.5232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eisenberg S. P., Evans R. J., Arend W. P., Verderber E., Brewer M. T., Hannum C. H., Thompson R. C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990 Jan 25;343(6256):341–346. doi: 10.1038/343341a0. [DOI] [PubMed] [Google Scholar]
- Finzel B. C., Clancy L. L., Holland D. R., Muchmore S. W., Watenpaugh K. D., Einspahr H. M. Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution. J Mol Biol. 1989 Oct 20;209(4):779–791. doi: 10.1016/0022-2836(89)90606-2. [DOI] [PubMed] [Google Scholar]
- Gehrke L., Jobling S. A., Paik L. S., McDonald B., Rosenwasser L. J., Auron P. E. A point mutation uncouples human interleukin-1 beta biological activity and receptor binding. J Biol Chem. 1990 Apr 15;265(11):5922–5925. [PubMed] [Google Scholar]
- Gilliland G. L., Winborne E. L., Masui Y., Hirai Y. A preliminary crystallographic study of recombinant human interleukin 1 beta. J Biol Chem. 1987 Sep 5;262(25):12323–12324. [PubMed] [Google Scholar]
- Graves B. J., Hatada M. H., Hendrickson W. A., Miller J. K., Madison V. S., Satow Y. Structure of interleukin 1 alpha at 2.7-A resolution. Biochemistry. 1990 Mar 20;29(11):2679–2684. doi: 10.1021/bi00463a009. [DOI] [PubMed] [Google Scholar]
- Gronenborn A. M., Wingfield P. T., McDonald H. R., Schmeissner U., Clore G. M. Site directed mutants of human interleukin-1 alpha: a 1H-NMR and receptor binding study. FEBS Lett. 1988 Apr 11;231(1):135–138. doi: 10.1016/0014-5793(88)80717-8. [DOI] [PubMed] [Google Scholar]
- Janin J., Chothia C. The structure of protein-protein recognition sites. J Biol Chem. 1990 Sep 25;265(27):16027–16030. [PubMed] [Google Scholar]
- Ju G., Collins L., Kaffka K. L., Tsien W. H., Chizzonite R., Crowl R., Bhatt R., Kilian P. L. Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity. J Biol Chem. 1987 Apr 25;262(12):5723–5731. [PubMed] [Google Scholar]
- Ju G., Labriola-Tompkins E., Campen C. A., Benjamin W. R., Karas J., Plocinski J., Biondi D., Kaffka K. L., Kilian P. L., Eisenberg S. P. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2658–2662. doi: 10.1073/pnas.88.7.2658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kamogashira T., Sakaguchi M., Ohmoto Y., Mizuno K., Shimizu R., Nagamura K., Nakai S., Masui Y., Hirai Y. Site-specific mutagenesis of the human interleukin-1 beta gene: the role of arginine residue at the N-terminal region. J Biochem. 1988 Nov;104(5):837–840. doi: 10.1093/oxfordjournals.jbchem.a122559. [DOI] [PubMed] [Google Scholar]
- Kilian P. L., Kaffka K. L., Stern A. S., Woehle D., Benjamin W. R., Dechiara T. M., Gubler U., Farrar J. J., Mizel S. B., Lomedico P. T. Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells. J Immunol. 1986 Jun 15;136(12):4509–4514. [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Limjuco G., Galuska S., Chin J., Cameron P., Boger J., Schmidt J. A. Antibodies of predetermined specificity to the major charged species of human interleukin 1. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3972–3976. doi: 10.1073/pnas.83.11.3972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacDonald H. R., Wingfield P., Schmeissner U., Shaw A., Clore G. M., Gronenborn A. M. Point mutations of human interleukin-1 with decreased receptor binding affinity. FEBS Lett. 1986 Dec 15;209(2):295–298. doi: 10.1016/0014-5793(86)81130-9. [DOI] [PubMed] [Google Scholar]
- Mizel S. B. Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1). Mol Immunol. 1980 May;17(5):571–577. doi: 10.1016/0161-5890(80)90155-8. [DOI] [PubMed] [Google Scholar]
- Mosley B., Dower S. K., Gillis S., Cosman D. Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4572–4576. doi: 10.1073/pnas.84.13.4572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naito Y., Fukata J., Masui Y., Hirai Y., Murakami N., Tominaga T., Nakai Y., Tamai S., Mori K., Imura H. Interleukin-1 beta analogues with markedly reduced pyrogenic activity can stimulate secretion of adrenocorticotropic hormone in rats. Biochem Biophys Res Commun. 1990 Feb 28;167(1):103–109. doi: 10.1016/0006-291x(90)91736-c. [DOI] [PubMed] [Google Scholar]
- Nakai S., Kawai K., Hirai Y., Tasaka K. A mutant protein of human interleukin-1 beta with immunostimulatory but not pyrogenic potency. Life Sci. 1990;47(19):1707–1714. doi: 10.1016/0024-3205(90)90343-p. [DOI] [PubMed] [Google Scholar]
- Paganelli K. A., Stern A. S., Kilian P. L. Detergent solubilization of the interleukin 1 receptor. J Immunol. 1987 Apr 1;138(7):2249–2253. [PubMed] [Google Scholar]
- Poindexter K., Jerzy R., Gayle R. B., 3rd Construction of interleukin-1 alpha mutants using unequal contamination of synthetic oligonucleotides. Nucleic Acids Res. 1991 Apr 25;19(8):1899–1904. doi: 10.1093/nar/19.8.1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Priestle J. P., Schär H. P., Grütter M. G. Crystal structure of the cytokine interleukin-1 beta. EMBO J. 1988 Feb;7(2):339–343. doi: 10.1002/j.1460-2075.1988.tb02818.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Priestle J. P., Schär H. P., Grütter M. G. Crystallographic refinement of interleukin 1 beta at 2.0 A resolution. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9667–9671. doi: 10.1073/pnas.86.24.9667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schär H. P., Priestle J. P., Grütter M. Crystallization and preliminary x-ray diffraction studies of recombinant human interleukin-1 beta. J Biol Chem. 1987 Oct 5;262(28):13724–13725. [PubMed] [Google Scholar]
- Sims J. E., Acres R. B., Grubin C. E., McMahan C. J., Wignall J. M., March C. J., Dower S. K. Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8946–8950. doi: 10.1073/pnas.86.22.8946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sims J. E., March C. J., Cosman D., Widmer M. B., MacDonald H. R., McMahan C. J., Grubin C. E., Wignall J. M., Jackson J. L., Call S. M. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science. 1988 Jul 29;241(4865):585–589. doi: 10.1126/science.2969618. [DOI] [PubMed] [Google Scholar]
- Yanofsky S. D., Zurawski G. Identification of key residues in the amino-terminal third of human interleukin-1 alpha. J Biol Chem. 1990 Aug 5;265(22):13000–13006. [PubMed] [Google Scholar]
- Yem A. W., Zurcher-Neely H. A., Richard K. A., Staite N. D., Heinrikson R. L., Deibel M. R., Jr Biotinylation of reactive amino groups in native recombinant human interleukin-1 beta. J Biol Chem. 1989 Oct 25;264(30):17691–17697. [PubMed] [Google Scholar]
- Zucali J. R., Moreb J., Newton R. C., Huaog J. J. Human N-terminal analogs of interleukin 1 beta demonstrate altered binding and function in hematopoiesis. Exp Hematol. 1990 Nov;18(10):1078–1082. [PubMed] [Google Scholar]